Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 18, 2022
Association of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Diabetic Kidney Disease in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study
Li L, Shen Q, Rao S
Therapeutics and Clinical Risk Management 2022, 18:1157-1166
Published Date: 28 December 2022
Diagnosis and Emerging Treatment Strategies for Mucopolysaccharidosis VII (Sly Syndrome)
Poswar FDO, Henriques Nehm J, Kubaski F, Poletto E, Giugliani R
Therapeutics and Clinical Risk Management 2022, 18:1143-1155
Published Date: 22 December 2022
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
Feldman M, Marmol S, Margolesky J
Therapeutics and Clinical Risk Management 2022, 18:1129-1142
Published Date: 20 December 2022
Incidence and Predictors of Adverse Drug Events Among People Receiving Drug Resistant Tuberculosis Treatment in Uganda: 8-Year Retrospective Cohort Study
Nasasira M, Kalyango JN, Mupere E, Baluku JB
Therapeutics and Clinical Risk Management 2022, 18:1117-1127
Published Date: 15 December 2022
Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management
Bolano-Diaz C, Diaz-Manera J
Therapeutics and Clinical Risk Management 2022, 18:1099-1115
Published Date: 13 December 2022
The Effect of Trigeminal Ganglion Block on Trigeminocardiac Reflex in Elderly Patients with Trigeminal Neuralgia Undergoing Percutaneous Balloon Compression: A Randomized Controlled Study
Zhang H, Liu M, Guo W, He J, Li J
Therapeutics and Clinical Risk Management 2022, 18:1091-1098
Published Date: 9 December 2022
Relationship Between Serum Indirect Bilirubin Levels and Cardiovascular Events and All-Cause Mortality in Maintenance Hemodialysis Patients
Chen Y, Zhao P, Fan W, Niu J
Therapeutics and Clinical Risk Management 2022, 18:1081-1090
Published Date: 6 December 2022
Drug-Related Problems in Pulmonary Hypertension with Valvular Heart Disease
Abdul-Ghaffar F, Md Redzuan A, Makmor-Bakry M, Muhamad Nor MA
Therapeutics and Clinical Risk Management 2022, 18:1069-1079
Published Date: 2 December 2022
Fixation by Autogenous Cortical Plate Technique on Sites of Subtrochanteric Shortening Osteotomy Contributes to Early Bone Union in Total Hip Arthroplasty for Crowe Type IV Developmental Dysplasia of the Hip
Liu Y, Zhang S, Li C, Ma M, Yang M, Guo R, Kong X, Chai W
Therapeutics and Clinical Risk Management 2022, 18:1059-1067
Published Date: 29 November 2022
Hard-Candy Consumption Does Not Have an Effect on Volume and pH of Gastric Content in Patients Undergoing Elective Gastrointestinal Endoscopic Procedures: A Randomized Controlled Trial
Somnuke P, Kitisin N, Chumklud P, Kunavuttitagool P, Deepinta P, Wadrod A, Prachayakul W, Amornyotin S, Raykateeraroj N
Therapeutics and Clinical Risk Management 2022, 18:1049-1057
Published Date: 28 November 2022
Quality and Characteristics of 4241 Case Reports of Lactic Acidosis in Metformin Users Reported to a Large Pharmacovigilance Database
Brand KMG, Schlachter J, Foch C, Boutmy E
Therapeutics and Clinical Risk Management 2022, 18:1037-1047
Published Date: 4 November 2022
Using a Double Syringe Sterile System for MSK Aspiration/Injection Procedures Eliminates Risk of Iatrogenic Infection
Lazarescu AE, Hogea BG, Andor BC, Totorean A, Cojocaru DG, Negru M, Bolintineanu LA, Patrascu Jnr JM, Misca LC, Sandesc MA, Patrascu Snr JM
Therapeutics and Clinical Risk Management 2022, 18:1029-1036
Published Date: 29 October 2022
Clinical Perspectives on Cardiac Rehabilitation After Heart Failure in Elderly Patients with Frailty: A Narrative Review
Tsukakoshi D, Yamamoto S, Takeda S, Furuhashi K, Sato M
Therapeutics and Clinical Risk Management 2022, 18:1009-1028
Published Date: 27 October 2022
Risk Factors for Midline Catheter Failure: A Secondary Analysis of an Existing Trial
Bahl A, Johnson S, Mielke N, Chen NW
Therapeutics and Clinical Risk Management 2022, 18:999-1007
Published Date: 7 October 2022
The Prediction of Surgery Outcomes in Abdominal Tumor Patients with Sepsis by Pcv-aCO2/Ca-cvO2
Lyu Y, Han T, Liu M, Cui K, Wang D
Therapeutics and Clinical Risk Management 2022, 18:989-997
Published Date: 7 October 2022
Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea
Kim J, Choi SW, Lee YS, Lee JM, Chung H, Woo JS, Kim WS, Choi YY, Kim W
Therapeutics and Clinical Risk Management 2022, 18:981-987
Published Date: 1 October 2022
Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New Opportunities
Chetta A, Facciolongo N, Franco C, Franzini L, Piraino A, Rossi C
Therapeutics and Clinical Risk Management 2022, 18:965-979
Published Date: 1 October 2022
Tirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?
Razzaki TS, Weiner A, Shukla AP
Therapeutics and Clinical Risk Management 2022, 18:955-964
Published Date: 28 September 2022
Use of a Minimally Invasive Traction Repositor versus Conventional Manual Traction for the Treatment of Tibial Fractures: A Comparative Study from a Tertiary Hospital in China
Zha J, Zhang G, Wang X, Li J, Di J, Guo J
Therapeutics and Clinical Risk Management 2022, 18:945-954
Published Date: 23 September 2022
Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)
Secord E, Hartog NL
Therapeutics and Clinical Risk Management 2022, 18:939-944
Published Date: 22 September 2022
Management of Open Tile C Pelvic Fractures and Their Outcomes: A Retrospective Study of 30 Cases
Lu S, Liu F, Xu W, Zhou X, Li L, Zhou D, Li Q, Dong J
Therapeutics and Clinical Risk Management 2022, 18:929-937
Published Date: 10 September 2022
A Literature Review of Ozanimod Therapy in Inflammatory Bowel Disease: From Concept to Practical Application
Becher N, Swaminath A, Sultan K
Therapeutics and Clinical Risk Management 2022, 18:913-927
Published Date: 8 September 2022
Intracranial Solitary Fibrous Tumor/Hemangiopericytoma Treated with Microsurgical Resection: Retrospective Cohort Analysis of a Single-Center Experience
Swaminathan S, Ruzevick J, Venur V, Halasz LM, Rockhill J, Gonzalez-Cuyar L, Cranmer LD, Ferreira Jnr M
Therapeutics and Clinical Risk Management 2022, 18:901-912
Published Date: 5 September 2022
A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease
Xie Z, Li J, Yang S, Deng W, Chen J
Therapeutics and Clinical Risk Management 2022, 18:889-900
Published Date: 30 August 2022
Quantitative Evaluation of Biceps Brachii Muscle by Shear Wave Elastography in Stroke Patients
Wei HQ, Gan M, Li GY, Ma SH, Liu JH
Therapeutics and Clinical Risk Management 2022, 18:879-887
Published Date: 3 October 2022
Long-Term Consequences of Increased Activity of Urine Enzymes After Cardiac Surgery – A Prospective Observational Study
Biernawska J, Kotfis K, Szymańska-Pasternak J, Bogacka A, Bober J
Therapeutics and Clinical Risk Management 2022, 18:867-877
Published Date: 26 August 2022
The Association Between Circulating Sex Hormones and Central Serous Chorioretinopathy: A Case-Control Study
Zhao C, Huang Y, Chen L, Ye S, Liu XQ
Therapeutics and Clinical Risk Management 2022, 18:855-865
Published Date: 25 August 2022
Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database
Hata T, Hirata A, Ota R, Hosohata K, Nishihara M, Neo M, Katsumata T
Therapeutics and Clinical Risk Management 2022, 18:843-853
Published Date: 24 August 2022
Impacts of Surgeons’ Experience on Patients with Epiretinal Membrane: A Retrospective Study from 2015 to 2020 in Wenzhou Eye Hospital
Lin W, Ren W, Chen H, Wei Y
Therapeutics and Clinical Risk Management 2022, 18:835-841
Published Date: 20 August 2022
Discrepancy Between Forceps Biopsy and Resection in Colorectal Polyps: A 1686 Paired Screening-Therapeutic Colonoscopic Finding [Corrigendum]
Jiang Y, Wang J, Chen Y, Sun H, Dong Z, Xu S
Therapeutics and Clinical Risk Management 2022, 18:833-834
Published Date: 18 August 2022
Optimal Use of Perampanel in Elderly Asian Patients with Epilepsy: Expert Opinion
Huang CW, Boonyapisit K, Gunadharma S, Casanova-Gutierrez J, Jin L, Nayak D, Akamatsu N
Therapeutics and Clinical Risk Management 2022, 18:825-832
Published Date: 16 August 2022
Comparison of Diagnostic Value Between STE+LDDSE and CMR-FT for Evaluating Coronary Microvascular Obstruction in Post-PCI Patients for STEMI
Liu T, Wang C, Yin J, Wang L, Xuan H, Yan Y, Chen J, Bao J, Li D, Xu T
Therapeutics and Clinical Risk Management 2022, 18:813-823
Published Date: 15 August 2022
Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis
Wang Z, Li H, Kang Y, Liu Y, Shan L, Wang F
Therapeutics and Clinical Risk Management 2022, 18:799-812
Published Date: 13 August 2022
Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study
Lin Q, Lu Y, Lu R, Chen Y, Wang L, Lu J, Ye X
Therapeutics and Clinical Risk Management 2022, 18:789-798
Published Date: 9 August 2022
Vitamin D Reduces Falls and Hip Fractures in Vascular Parkinsonism but Not in Parkinson’s Disease [Retraction]
Sato Y, Iwamoto J, Honda Y, Amano N
Therapeutics and Clinical Risk Management 2022, 18:787-788
Published Date: 10 August 2022
Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H
Therapeutics and Clinical Risk Management 2022, 18:785-786
Published Date: 10 August 2022
Intertrochanteric Fracture Surgery Patients with Diabetes Mellitus are Prone to Suffer Perioperative Neurological and Endocrine/Metabolic Complications: A Propensity-Score Matched Analysis
Tang Y, Kang L, Guo M, Fan L
Therapeutics and Clinical Risk Management 2022, 18:775-783
Published Date: 6 August 2022
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum]
Waheed W, Newman E, Aboukhatwa M, Moin M, Tandan R
Therapeutics and Clinical Risk Management 2022, 18:773-774
Published Date: 3 August 2022
Indocyanine Green Retention Test as a Predictor of Postoperative Complications in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
Mai RY, Bai T, Luo XL, Wu GB
Therapeutics and Clinical Risk Management 2022, 18:761-772
Published Date: 2 August 2022
Role of Finerenone in the Treatment of Diabetic Kidney Disease: Patient Selection and Clinical Perspectives
Shaikh A, Ray J, Campbell KN
Therapeutics and Clinical Risk Management 2022, 18:753-760
Published Date: 29 July 2022
Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine Tumors
Molasy B, Zemła P, Mrowiec S, Grudzińska E, Kuśnierz K
Therapeutics and Clinical Risk Management 2022, 18:745-752
Published Date: 29 July 2022
Modified Perineal Reconstruction Combined with Anal Sphincter Repair for Obstetric Anal Sphincter Injuries
Wang X, Liu YN, Sun D, Chen S, Huang BL, Tai JD
Therapeutics and Clinical Risk Management 2022, 18:739-744
Published Date: 28 July 2022
Is There a Doctors’ Effect on Patients’ Physical Health, Beyond the Intervention and All Known Factors? A Systematic Review
Schnelle C, Clark J, Mascord R, Jones MA
Therapeutics and Clinical Risk Management 2022, 18:721-737
Published Date: 21 July 2022
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review
Waheed W, Newman E, Aboukhatwa M, Moin M, Tandan R
Therapeutics and Clinical Risk Management 2022, 18:699-719
Published Date: 12 July 2022
A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma
Tiako Meyo M, Chen J, Goldwasser F, Hirsch L, Huillard O
Therapeutics and Clinical Risk Management 2022, 18:683-698
Published Date: 8 July 2022
Characteristics and Consequences of Medication Errors in Pediatric Patients Reported to Ramathibodi Poison Center: A 10-Year Retrospective Study
Tansuwannarat P, Vichiensanth P, Sivarak O, Tongpoo A, Promrungsri P, Sriapha C, Wananukul W, Trakulsrichai S
Therapeutics and Clinical Risk Management 2022, 18:669-681
Published Date: 30 June 2022
Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First
Deshpande A, Munoz J
Therapeutics and Clinical Risk Management 2022, 18:657-668
Published Date: 23 June 2022
Management Practice and Drug Related Problems and Its Contributing Factors Among Cervical Cancer Patients at Oncologic Center in Ethiopia: A Hospital-Based Retrospective Study
Kefale B, Engidaw MT, Tesfa D, Molla M, Yismaw MB
Therapeutics and Clinical Risk Management 2022, 18:643-655
Published Date: 10 June 2022
Cumulative Doses Predict the Risk of Furosemide-Induced Electrolyte Abnormalities in Critically Ill Neonates
Sridharan K, Al Madhoob A, Al Jufairi M
Therapeutics and Clinical Risk Management 2022, 18:633-641
Published Date: 9 June 2022
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
Iaxx R, Lefort F, Domblides C, Ravaud A, Bernhard JC, Gross-Goupil M
Therapeutics and Clinical Risk Management 2022, 18:619-632
Published Date: 2 June 2022
Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
Lagier JC, Million M, Cortaredona S, Delorme L, Colson P, Fournier PE, Brouqui P, Raoult D, Parola P
Therapeutics and Clinical Risk Management 2022, 18:603-617
Published Date: 31 May 2022
Extensive Radiological Manifestation in Patients with Diabetes and Pulmonary Tuberculosis: A Cross-Sectional Study
Zhan S, Juan X, Ren T, Wang Y, Fu L, Deng G, Zhang P
Therapeutics and Clinical Risk Management 2022, 18:595-602
Published Date: 23 May 2022
The Role of D-Dimers in the Initial Evaluation of COVID-19 [Response To Letter]
Baroiu L, Lese AC, Stefanopol IA, Iancu A, Dumitru C, Ciubara AB, Bujoreanu FC, Baroiu N, Ciubara A, Nechifor A, Anghel L, Tatu AL
Therapeutics and Clinical Risk Management 2022, 18:593-594
Published Date: 20 May 2022
Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China
Jiang J, Zhong W, Huang W, Gao Y, He Y, Li X, Liu Z, Zhou H, Fu Y, Liu R, Zhang W
Therapeutics and Clinical Risk Management 2022, 18:579-591
Published Date: 17 May 2022
The Changes of Thyroid Function and Related Factors in Critical Patients without Thyroid Illness in ICU: A Retrospective Cross-Sectional Study
Zhang JN, Zhao XL
Therapeutics and Clinical Risk Management 2022, 18:571-578
Published Date: 16 May 2022
Discrepancy Between Forceps Biopsy and Resection in Colorectal Polyps: A 1686 Paired Screening-Therapeutic Colonoscopic Finding
Jiang Y, Wang J, Chen Y, Sun H, Dong Z, Xu S
Therapeutics and Clinical Risk Management 2022, 18:561-569
Published Date: 16 May 2022
Surgical Treatment of Clavicular Fractures, Refractures, Delayed and Non-Unions Using a Resorbable, Gentamicin-Eluting Calcium Sulphate/Hydroxyapatite Biocomposite
Peters J, Singh G, Hakobyan H
Therapeutics and Clinical Risk Management 2022, 18:551-560
Published Date: 9 May 2022
Which Frailty Evaluation Method Can Better Improve the Predictive Ability of the SASA for Postoperative Complications of Patients Undergoing Elective Abdominal Surgery?
Yin Y, Jiang L, Xue L
Therapeutics and Clinical Risk Management 2022, 18:541-550
Published Date: 5 May 2022
Systematic Review and Meta-Analysis on Colorectal Anastomotic Techniques
Steger J, Jell A, Ficht S, Ostler D, Eblenkamp M, Mela P, Wilhelm D
Therapeutics and Clinical Risk Management 2022, 18:523-539
Published Date: 4 May 2022
Clinical, Imaging, Histological and Surgical Aspects Regarding Giant Paraovarian Cysts: A Systematic Review
Stefanopol IA, Baroiu L, Neagu AI, Danila DM, Nechifor A, Miulescu M, Balan G, Vasile CI, Niculet E, Tatu AL
Therapeutics and Clinical Risk Management 2022, 18:513-522
Published Date: 29 April 2022
Letter to the Editor: The Role of D-Dimers in the Initial Evaluation of COVID-19 [Letter]
Patel S
Therapeutics and Clinical Risk Management 2022, 18:511-512
Published Date: 28 April 2022
Treatment and Outcome of Castleman Disease: A Retrospective Report of 31 Patients
Tang D, Guo Y, Tang Y, Wang H
Therapeutics and Clinical Risk Management 2022, 18:499-509
Published Date: 26 April 2022
The Course and Anatomical Characteristics of Sciatic and Femoral Nerves in Unilateral Crowe Type-IV Hip Dysplasia
Song P, Kong X, Yang M, Ma M, Chai W
Therapeutics and Clinical Risk Management 2022, 18:491-497
Published Date: 26 April 2022
Is There a Surgeons’ Effect on Patients’ Physical Health, Beyond the Intervention, That Requires Further Investigation? A Systematic Review
Schnelle C, Clark J, Mascord R, Jones MA
Therapeutics and Clinical Risk Management 2022, 18:467-490
Published Date: 26 April 2022
A Nomogram for Predicting In-Hospital Major Adverse Cardio- and Cerebro-Vascular Events in Patients Undergoing Major Noncardiac Surgery: A Large-Scale Nested Case-Control Study
Wu X, Zhang J, Hu M, Gu L, Li K, Yang X
Therapeutics and Clinical Risk Management 2022, 18:457-465
Published Date: 22 April 2022
Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations
Cohen F, Yuan H
Therapeutics and Clinical Risk Management 2022, 18:447-456
Published Date: 22 April 2022
Tuberculosis Surveillance in Romania Among Vulnerable Risk Groups Between 2015 and 2017
Munteanu I, Cioran N, van Hest R, Abubakar I, Story A, Chiotan D, de Vries G, Mahler B
Therapeutics and Clinical Risk Management 2022, 18:439-446
Published Date: 20 April 2022
Diagnostic Value of Serum Levels of IL-22, IL-23, and IL-17 for Idiopathic Pulmonary Fibrosis Associated with Lung Cancer
Zhang Q, Tong L, Wang B, Wang T, Ma H
Therapeutics and Clinical Risk Management 2022, 18:429-437
Published Date: 19 April 2022
High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients
Kucuk A, Topkan E, Selek U, Haksoyler V, Mertsoylu H, Besen AA, Pehlivan B
Therapeutics and Clinical Risk Management 2022, 18:421-428
Published Date: 14 April 2022
An Analysis of the Risk Factors for Adding-on Phenomena After Posterior Hemivertebral Resection and Pedicle Screw Fixation for the Treatment of Congenital Scoliosis Caused by Hemivertebral Malformation
Bao BX, Yan H, Tang JG, Qiu DJ, Wu YX, Cheng XK
Therapeutics and Clinical Risk Management 2022, 18:409-419
Published Date: 13 April 2022
Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives
Niculet E, Bobeica C, Stefanopol IA, Pelin AM, Nechifor A, Onisor C, Tatu AL
Therapeutics and Clinical Risk Management 2022, 18:399-407
Published Date: 13 April 2022
Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan
Ahmed KO, Ahmed AM, Wali MB, Ali AH, Azhari MM, Babiker A, Yousef BA, Muddather HF
Therapeutics and Clinical Risk Management 2022, 18:391-398
Published Date: 8 April 2022
The Use of Muscle Relaxants and Reversal Agents in a Setting Without Cost Restrictions: Experience from a Tertiary Academic Hospital in the Netherlands
Martini CH, Honing GHM, Bash LD, Olofsen E, Niesters M, van Velzen M, Dahan A, Boon M
Therapeutics and Clinical Risk Management 2022, 18:379-390
Published Date: 8 April 2022
Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
De Matteis E, Sacco S, Ornello R
Therapeutics and Clinical Risk Management 2022, 18:359-378
Published Date: 5 April 2022
Single Nucleotide Polymorphism in the 3’ Untranslated Region of PRKAA2 on Cardiometabolic Parameters in Type 2 Diabetes Mellitus Patients Who Received Metformin
Virginia DM, Patramurti C, Fenty, Setiawan CH, Julianus J, Hendra P, Susanto NAP
Therapeutics and Clinical Risk Management 2022, 18:349-357
Published Date: 5 April 2022
Recombinant Activated Factor VII in Aortic Surgery for Patients Under Hypothermic Circulatory Arrest
Ise H, Ushioda R, Kanda H, Kimura F, Saijo Y, Akhyari P, Lichtenberg A, Kamiya H
Therapeutics and Clinical Risk Management 2022, 18:337-348
Published Date: 5 April 2022
The Role of D-Dimers in the Initial Evaluation of COVID-19
Baroiu L, Lese AC, Stefanopol IA, Iancu A, Dumitru C, Ciubara AB, Bujoreanu FC, Baroiu N, Ciubara A, Nechifor A, Anghel L, Tatu AL
Therapeutics and Clinical Risk Management 2022, 18:323-335
Published Date: 31 March 2022
Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations
Kassis-George H, Verlinden NJ, Fu S, Kanwar M
Therapeutics and Clinical Risk Management 2022, 18:315-322
Published Date: 30 March 2022
Ultrasound-Guided Posterior Quadratus Lumborum Block for Acute Postoperative Analgesia in Adult Patients: A Meta-Analysis of Randomized Controlled Trials
Lin C, Wang X, Qin C, Liu J
Therapeutics and Clinical Risk Management 2022, 18:299-313
Published Date: 29 March 2022
Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis
Han YR, Wang TH, Gong WP, Liang JQ, An HR
Therapeutics and Clinical Risk Management 2022, 18:287-298
Published Date: 25 March 2022
Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
Tsykunova G, Ghanima W
Therapeutics and Clinical Risk Management 2022, 18:273-286
Published Date: 24 March 2022
Early Detection of Iron Overload Cardiomyopathy in Transfusion Dependent Thalassemia Patients in Sulaimaniyah City, Iraq
Ahmed RA, Salih AF, Omer SH, Rahman HS, Rasool LK
Therapeutics and Clinical Risk Management 2022, 18:259-271
Published Date: 22 March 2022
Strategy to Reduce Hypercapnia in Robot-Assisted Radical Prostatectomy Using Transcutaneous Carbon Dioxide Monitoring: A Prospective Observational Study
Lee HJ, Chae JS, An SM, Oh HW, Kim YJ, Woo JH
Therapeutics and Clinical Risk Management 2022, 18:249-258
Published Date: 17 March 2022
Diagnosis and Management of Genetic Causes of Middle Aortic Syndrome in Children: A Comprehensive Literature Review
Lazea C, Al-Khzouz C, Sufana C, Miclea D, Asavoaie C, Filimon I, Fufezan O
Therapeutics and Clinical Risk Management 2022, 18:233-248
Published Date: 16 March 2022
Evaluating the Safety of Maribavir for the Treatment of Cytomegalovirus
Gandhi RG, Kotton CN
Therapeutics and Clinical Risk Management 2022, 18:223-232
Published Date: 12 March 2022
Left Atrial Strain Helps Identifying the Cardioembolic Risk in Transient Ischemic Attacks Patients with Silent Paroxysmal Atrial Fibrillation
Arnăutu SF, Morariu VI, Arnăutu DA, Tomescu MC, Dan TF, Jianu CD
Therapeutics and Clinical Risk Management 2022, 18:213-222
Published Date: 10 March 2022
Effects of Combination Treatment in Hypertensive Patients with Depression: A Systematic Review and Meta-Analysis of 27 Randomized Controlled Trials
Wang L, Liu Q, Sun D, Xie J, Lao D, Zhang L
Therapeutics and Clinical Risk Management 2022, 18:197-211
Published Date: 5 March 2022
Research Progress of Olfactory Nerve Regeneration Mechanism and Olfactory Training
Hu B, Zhang J, Gong M, Deng Y, Cao Y, Xiang Y, Ye D
Therapeutics and Clinical Risk Management 2022, 18:185-195
Published Date: 5 March 2022
Vitamin D Reduces Falls and Hip Fractures in Vascular Parkinsonism but Not in Parkinson’s Disease [Expression of Concern]
Sato Y, Iwamoto J, Honda Y, Amano N
Therapeutics and Clinical Risk Management 2022, 18:183-184
Published Date: 4 March 2022
An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
Frankel J, Staskin D, Varano S, Kennelly MJ, Jankowich RA, Haag-Molkenteller C
Therapeutics and Clinical Risk Management 2022, 18:171-182
Published Date: 3 March 2022
Development and Validation of a Clinical and Laboratory-Based Nomogram for Predicting Coronary Microvascular Obstruction in NSTEMI Patients After Primary PCI
Liu T, Wang C, Wang L, Shi X, Li X, Chen J, Xuan H, Li D, Xu T
Therapeutics and Clinical Risk Management 2022, 18:155-169
Published Date: 27 February 2022
Comparison of Outcome and Quality of Life Between Thulium Laser (VelaTM XL) Enucleation of Prostate and Bipolar Transurethral Enucleation of the Prostate (B-TUEP)
Chen YT, Hou CP, Juang HH, Lin YH, Yang PS, Chang PL, Chen CL, Weng SC, Tsui KH
Therapeutics and Clinical Risk Management 2022, 18:145-154
Published Date: 24 February 2022
Percutaneous Internal Ring Suturing (PIRS) – The Benefits of Laparoscopic Inguinal Hernia Repair
Wolak PK, Strzelecka A, Piotrowska - Gall A, Wolak PP, Piotrowska I, Dąbrowska K, Wróbel J, Nowak-Starz G
Therapeutics and Clinical Risk Management 2022, 18:135-144
Published Date: 22 February 2022
Poor Sensorium at the Time of Intubation Predicts Polymicrobial Ventilator Associated Pneumonia
Natarajan R, Ramanathan V, Sistla S
Therapeutics and Clinical Risk Management 2022, 18:125-133
Published Date: 17 February 2022
A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency
Gou P, Cheng X, Leng J, Su N
Therapeutics and Clinical Risk Management 2022, 18:113-124
Published Date: 16 March 2022
Multivariable Analysis of Risk Factors Affecting Dislocation After Bipolar Hemiarthroplasty in Patients with Femoral Neck Fracture
Yang Y, Fu G, Li Q, Zhang R, Liao W, Ma Y, Zheng Q
Therapeutics and Clinical Risk Management 2022, 18:101-111
Published Date: 9 February 2022
Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures
Morimoto Y
Therapeutics and Clinical Risk Management 2022, 18:95-100
Published Date: 2 February 2022
Effectiveness of Biofeedback Therapy in Patients with Bowel Dysfunction Following Rectal Cancer Surgery: A Systemic Review with Meta-Analysis
Li H, Guo C, Gao J, Yao H
Therapeutics and Clinical Risk Management 2022, 18:71-93
Published Date: 2 February 2022
Risk Factors for Asymptomatic and Symptomatic Intracranial Atherosclerosis Determined by Magnetic Resonance Vessel Wall Imaging in Chinese Population: A Case–Control Study
Han Y, Zhang R, Yang D, Li D, Han H, Qiao H, Chen S, Wang Y, Yu M, Hong Y, Wang Z, Zhao X, Liu G
Therapeutics and Clinical Risk Management 2022, 18:61-70
Published Date: 12 January 2022
Pediatric Adrenal Insufficiency: Challenges and Solutions
Nisticò D, Bossini B, Benvenuto S, Pellegrin MC, Tornese G
Therapeutics and Clinical Risk Management 2022, 18:47-60
Published Date: 11 January 2022
Prognostic Implications of the Admission Cardiac Troponin I Levels and Door-to-Balloon Time on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Zhao L, Xin M, Piao X, Zhang S, Li Y, Cheng XW
Therapeutics and Clinical Risk Management 2022, 18:31-45
Published Date: 7 January 2022
Nutritional and Physical Prehabilitation in Elective Orthopedic Surgery: Rationale and Proposal for Implementation
Briguglio M, Wainwright TW
Therapeutics and Clinical Risk Management 2022, 18:21-30
Published Date: 6 January 2022
Efficacy and Safety of Radiofrequency Ablation for the Treatment of Autonomously Functioning Thyroid Nodules: A Long-Term Prospective Study
Vu DL, Pham MT, Nguyen VB, Le TM
Therapeutics and Clinical Risk Management 2022, 18:11-19
Published Date: 6 January 2022
Delays to Hospital Presentation in Women and Men with ST-Segment Elevation Myocardial Infarction: A Multi-Center Analysis of Patients Hospitalized in New York City
Weininger D, Cordova JP, Wilson E, Eslava DJ, Alviar CL, Korniyenko A, Bavishi CP, Hong MK, Chorzempa A, Fox J, Tamis-Holland JE
Therapeutics and Clinical Risk Management 2022, 18:1-9
Published Date: 4 January 2022